Summary
In order to study the heterogeneity of Type 2 (non-insulin-dependent) diabetes, we determined HLA antigens and measured B-cell function as C-peptide response to intravenous glucagon in 217 patients with onset of non-ketotic diabetes after the age of 40 years. Their HLA frequencies were compared with those of Type 1 (insulin-dependent) diabetic patients and of healthy blood donors. The Type 1 diabetic patients showed a typical HLA pattern, with increased frequencies of B15, DR3, DR4, B8/B15 and DR3/DR4 and decreased frequencies of 137 and DR2. The Type 2 diabetic patients could be distinguished from blood donors by increased frequencies of Cw4, DR4, DR5 and DR3/DR4, and from Type 1 diabetic patients by increased frequencies of B7, DR2, DR5 and decreased frequency of A9, Bw22 and DR4. Age at onset and body mass index were unrelated to HLA antigens, but the Type 2 diabetic patients with HLA-Cw4, DR5 and DR6 showed a strong family history for Type 2 diabetes. Type 2 diabetic patients with HLA-B8, DR4, B8/B15 and DR3/DR4 showed significantly lower C-peptide concentrations (p < 0.05) than patients without these HLA antigens. In contrast, patients with DR5 and DRw8 presented with high C-peptide levels. Twelve patients who were positive for both DR3 and DR4 and 23 patients who were DR3/DR4 negative were followed with repeated C-peptide determinations during a period of three years. The C-peptide concentrations of the DR3/DR4 positive patients decreased during this period, whereas there was no change in C-peptide levels in the DR3/DR4 negative patients. In conclusion, B-cell function measured as C-peptide response to glucagon correlates with HLA antigens in patients with onset of diabetes after age 40. Impaired B-cell function seems to be associated with Type 1 diabetes-related HLA-antigens, whereas the presence of DR5 was associated with preserved B-cell function and a strong heredity for Type 2 diabetes. The results thus support the concept of heterogeneity in Type 2 diabetes. Admixture of patients with latent Type 1 diabetes can at least partially account for this heterogeneity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039–1057
Fajans SS, Cloutier MC, Crowther RL (1978) Clinical and etiologic heterogeneity of idiopathic diabetes mellitus. Diabetes 27: 1112–1125
Groop L (1982) Heterogeneity of Type 2 diabetes. A study of clinical, genetic, immunological and metabolic aspects. Thesis, University of Helsinki
Bottazzo GF (1984) Beta-cell damage in diabetic insulitis: are we approaching a solution? Diabetologia 26: 241–249
Cudworth AG (1978) Type 1 diabetes mellitus. Diabetologia 14: 281–291
Wolf E, Spencer KM, Cudworth AG (1983) The genetic susceptibility to Type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association. Diabetologia 24: 224–230
Groop L, Koskimies S, Pelkonen R, Tolppanen EM (1983) Increased frequency of HLA-Cw4 in type 2 diabetes. Acta Endocrinol 104: 475–478
Faber OK, Binder C (1977) C-peptide response to glucagon. A test for residual beta-cell function. Diabetes 26: 605–610
Heding LG (1975) Radioimmunological determination of C-peptide in serum. Diabetologia 11: 541–548
Ray JG, Hare DB, Pedersen PD, Mullaly DI (eds) (1976–1977) NIAID Manual of tissue typing techniques. Institute of Health, Bethesda, MD, DREW 76-545, p 22
Dixon WJ (ed) (1981) BMDP statistical software. University of California Press, Berkely
Platz P, Jakobsen BY, Marling N, Ryder LP, Svejgaard A, Thomsen M, Christy M, Kromann H, Benn J, Nerup J, Green A, Hange M (1981) HLA-D and DR-antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia 21: 108–115
Jakobsen BK, Morling N, Platz P, Ryder LP, Thomsen M, Svejgaard A (1981) HLA-DR phenotype and HLA-B, DR haplotype frequencies in 704 unrelated Danes. Tissue antigens 18: 270–275
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Groop, L., Groop, P.H. & Koskimies, S. Relationship between B-cell function and HLA antigens in patients with Type 2 (non-insulin-dependent) diabetes. Diabetologia 29, 757–760 (1986). https://doi.org/10.1007/BF00873212
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00873212